Epidemiology of a mumps outbreak in a highly vaccinated island population and use of a third dose of measles-mumps-rubella vaccine for outbreak control--Guam 2009 to 2010
- PMID: 23099425
- PMCID: PMC6893844
- DOI: 10.1097/INF.0b013e318279f593
Epidemiology of a mumps outbreak in a highly vaccinated island population and use of a third dose of measles-mumps-rubella vaccine for outbreak control--Guam 2009 to 2010
Abstract
Background: Despite high 2-dose measles-mumps-rubella (MMR) vaccine coverage, a large mumps outbreak occurred on the US Territory of Guam during 2009 to 2010, primarily in school-aged children.
Methods: We implemented active surveillance in April 2010 during the outbreak peak and characterized the outbreak epidemiology. We administered third doses of MMR vaccine to eligible students aged 9-14 years in 7 schools with the highest attack rates (ARs) between May 18, 2010, and May 21, 2010. Baseline surveys, follow-up surveys and case-reports were used to determine mumps ARs. Adverse events postvaccination were monitored.
Results: Between December 1, 2009, and December 31, 2010, 505 mumps cases were reported. Self-reported Pohnpeians and Chuukese had the highest relative risks (54.7 and 19.7, respectively) and highest crowding indices (mean: 3.1 and 3.0 persons/bedroom, respectively). Among 287 (57%) school-aged case-patients, 270 (93%) had ≥2 MMR doses. A third MMR dose was administered to 1068 (33%) eligible students. Three-dose vaccinated students had an AR of 0.9/1000 compared with 2.4/1000 among students vaccinated with ≤2 doses >1 incubation period postintervention, but the difference was not significant (P = 0.67). No serious adverse events were reported.
Conclusions: This mumps outbreak occurred in a highly vaccinated population. The highest ARs occurred in ethnic minority populations with the highest household crowding indices. After the third dose MMR intervention in highly affected schools, 3-dose recipients had an AR 60% lower than students with ≤2 doses, but the difference was not statistically significant and the intervention occurred after the outbreak peaked. This outbreak may have persisted due to crowding at home and high student contact rates.
Conflict of interest statement
Figures




Similar articles
-
Impact of a third dose of measles-mumps-rubella vaccine on a mumps outbreak.Pediatrics. 2012 Dec;130(6):e1567-74. doi: 10.1542/peds.2012-0177. Epub 2012 Nov 5. Pediatrics. 2012. PMID: 23129075
-
Effectiveness of a Third Dose of MMR Vaccine for Mumps Outbreak Control.N Engl J Med. 2017 Sep 7;377(10):947-956. doi: 10.1056/NEJMoa1703309. N Engl J Med. 2017. PMID: 28877026 Free PMC article.
-
Mumps vaccine effectiveness and risk factors for disease in households during an outbreak in New York City.Vaccine. 2014 Jan 9;32(3):369-74. doi: 10.1016/j.vaccine.2013.11.021. Epub 2013 Nov 16. Vaccine. 2014. PMID: 24252695
-
Vaccines for measles, mumps, rubella, and varicella in children.Cochrane Database Syst Rev. 2020 Apr 20;4(4):CD004407. doi: 10.1002/14651858.CD004407.pub4. Cochrane Database Syst Rev. 2020. Update in: Cochrane Database Syst Rev. 2021 Nov 22;11:CD004407. doi: 10.1002/14651858.CD004407.pub5. PMID: 32309885 Free PMC article. Updated.
-
Measles, mumps, rubella prevention: how can we do better?Expert Rev Vaccines. 2021 Jul;20(7):811-826. doi: 10.1080/14760584.2021.1927722. Epub 2021 Jun 7. Expert Rev Vaccines. 2021. PMID: 34096442 Review.
Cited by
-
A Multi-Age-Group Interrupted Time-Series Study for Evaluating the Effectiveness of National Expanded Program on Immunization on Mumps.Vaccines (Basel). 2022 Sep 21;10(10):1587. doi: 10.3390/vaccines10101587. Vaccines (Basel). 2022. PMID: 36298452 Free PMC article.
-
Epidemiologic features of mumps in Taiwan from 2006 to 2011: a new challenge for public health policy.World J Pediatr. 2015 May;11(2):141-7. doi: 10.1007/s12519-014-0525-6. Epub 2014 Nov 22. World J Pediatr. 2015. PMID: 25416005
-
Mumps Outbreaks in Vaccinated Populations-Is It Time to Re-assess the Clinical Efficacy of Vaccines?Front Immunol. 2020 Sep 18;11:2089. doi: 10.3389/fimmu.2020.02089. eCollection 2020. Front Immunol. 2020. PMID: 33072071 Free PMC article. Review.
-
Mumps in the Vaccination Age: Global Epidemiology and the Situation in Germany.Int J Environ Res Public Health. 2018 Jul 31;15(8):1618. doi: 10.3390/ijerph15081618. Int J Environ Res Public Health. 2018. PMID: 30065192 Free PMC article. Review.
-
Upward Trends of Parotitis and Mumps in Atlanta over a Decade.Glob Pediatr Health. 2020 Oct 29;7:2333794X20968676. doi: 10.1177/2333794X20968676. eCollection 2020. Glob Pediatr Health. 2020. PMID: 33195746 Free PMC article.
References
-
- Koskiniemi M, Donner M, Pettay O. Clinical appearance and outcome in mumps encephalitis in children. Acta Paediatr Scand 1983. July;72(4):603–9. - PubMed
-
- Everberg G Deafness following mumps. Acta Otolaryngol 1957. Nov-Dec;48(5–6):397–403. - PubMed
-
- Tarkkanen J, Aho J. Unilateral deafness in children. Acta Otolaryngol 1966. March;61(3):270–8. - PubMed
-
- Falk WA, Buchan K, Dow M, et al. The epidemiology of mumps in southern Alberta 1980–1982. Am J Epidemiol 1989. October;130(4):736–49. - PubMed
-
- CDC. Notice to Readers: Updated Recommendations of the Advisory Committee on Immunization Practices (ACIP) for the Control and Elimination of Mumps. MMWR Morb Mortal Wkly Rep 2006;55(22):629–30. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous